Skip to main content
. 2016 Jan 10;7(3):324–334. doi: 10.7150/jca.13422

Table 1.

Correlation between PIM1 expression and the clinicopathological characteristics.

Variables Number of Patients PIM1 expression (%) χ2 *P-value
Low/none High
Gender
Female 72 33(45.8) 39(54.2) 5.508 0.019
Male 122 77(63.1) 45(36.9)
Age (years)
< 60 101 53(52.5) 48(47.5) 1.532 0.216
≥ 60 93 57(61.3) 36(38.7)
Smoking index
< 400 95 55 (54.7) 43(45.3) 0.293 0.589
≥ 400 99 58(58.6) 41(41.4)
Clinical Stage
I 84 48(57.1) 36(42.9) 3.206 0.361
II 43 28(65.1) 15(34.9)
IIIa 54 29(53.7) 25(46.3)
IIIb 13 5(38.5) 8(61.5)
Tumor size
≤ 3cm 92 45(48.9) 47(51.1) 4.323 0.038
> 3cm 102 65(63.7) 37(36.3)
Regional LN metastasis
No 107 68(63.6) 39(36.4) 4.561 0.033
Yes 87 42(48.3) 45(51.7)
Distant metastasis
No 180 105(58.3) 75(41.7) 2.707 0.100
Yes 14 5(35.7) 9(64.3)
Histology
AD 101 47(46.5) 54(53.5) 8.870 0.003
SCC 93 63(67.7) 30(32.3)
Pathologic differentiation
Well 64 31(53.1) 33(46.9) 2.656 0.103
Poor 130 79(60.8) 51(39.2)
p-STAT3 expression
Low/ none 99 63(63.6) 36(36.4) 3.961 0.047
High 95 47(49.5) 48(50.5)
c-MYC expression
Low/ none 93 51(54.8) 42(45.2) 0.252 0.615
High 101 59(58.4) 42(41.6)
Total 194 110(56.7) 84(43.3)

LN: lymph node. SCC: squamous cell carcinoma. AD: adenocarcinoma. *P values < 0.05 in bold.